Literature DB >> 10571955

Cystic fibrosis mutations in Israeli Arab patients.

A Laufer-Cahana1, I Lerer, M Sagi, T Rachmilewitz-Minei, C Zamir, J R Rivlin, D Abeliovich.   

Abstract

Mutation analysis was performed on 42 unrelated Israeli Arab CF patients. The previously known mutations in this population, DF508, N1303K, G542X, 4010delTATT, and S549R(T>G), were identified in 57 CF alleles, leaving 28 CF alleles with unknown mutations. Screening of the coding sequence of the CFTR gene by a single strand conformation analysis (SSCA) and direct sequencing revealed three point mutations and two intragenic deletions, including 2183AA>G, R75X, S549R (A>C), 3120+1Kbdel8.6Kb and del(exon2). In the present sample of Israeli Arab patients, 12 mutations account for 92% of the CF alleles. The mutations DF508, N1303K, W1282X and 3120+1Kbdel8.6Kb were found in all Arab ethnic subgroups. The mutations G85E, R75X, 2183AA>G, and del(exon2) were confined to Muslim Arabs, and the mutations 4010delTATT, S549R(A>C) and G542X were confined to Christian Arabs. Hum Mutat 14:543, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10571955     DOI: 10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU16>3.0.CO;2-V

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

1.  A haplotype framework for cystic fibrosis mutations in Iran.

Authors:  Elahe Elahi; Ahmad Khodadad; Ilya Kupershmidt; Fereshteh Ghasemi; Babak Alinasab; Ramin Naghizadeh; Robert G Eason; Mahshid Amini; Mehran Esmaili; Mohammad R Esmaeili Dooki; Mohammad H Sanati; Ronald W Davis; Mostafa Ronaghi; Yvonne R Thorstenson
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

2.  Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.

Authors:  Issa Siryani; Mohamed Jama; Nisreen Rumman; Hiyam Marzouqa; Moein Kannan; Elaine Lyon; Musa Hindiyeh
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

3.  Next generation sequencing to determine the cystic fibrosis mutation spectrum in Palestinian population.

Authors:  O Essawi; M Farraj; K De Leeneer; W Steyaert; K De Pauw; A De Paepe; K Claes; T Essawi; P J Coucke
Journal:  Dis Markers       Date:  2015-01-26       Impact factor: 3.434

4.  Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening.

Authors:  Doron M Behar; Ori Inbar; Michal Shteinberg; Michal Gur; Huda Mussaffi; David Shoseyov; Moshe Ashkenazi; Soliman Alkrinawi; Concetta Bormans; Fahed Hakim; Meir Mei-Zahav; Malena Cohen-Cymberknoh; Adi Dagan; Dario Prais; Ifat Sarouk; Patrick Stafler; Bat El Bar Aluma; Gidon Akler; Elie Picard; Micha Aviram; Ori Efrati; Galit Livnat; Joseph Rivlin; Lea Bentur; Hannah Blau; Eitan Kerem; Amihood Singer
Journal:  Mol Genet Genomic Med       Date:  2017-02-19       Impact factor: 2.183

Review 5.  Cystic Fibrosis Gene Mutation Frequency Among a Group of Suspected Children in King Hussein Medical Center.

Authors:  Baheieh Al-Abadi; Mansour Al-Hiary; Rami Khasawneh; Asim Al-Momani; Ahmad Bani-Salameh; Sanaa Al-Saeidat; Alia Al-Khlaifat; Omaima Aboalsondos
Journal:  Med Arch       Date:  2019-04

6.  A novel cystic fibrosis gene mutation c.2490insT in a Palestinian patient: A case report and review of the literature.

Authors:  Hassan Chami; Samer Abou Arbid; Rebecca Badra; Chantal Farra
Journal:  Ann Thorac Med       Date:  2017 Oct-Dec       Impact factor: 2.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.